$4.43
0.04 (+0.91%)
Biodel, Inc. (NASDAQ:BIOD)
CAPS Rating:
A specialty pharmaceutical company, which focused on the development and commercialization of innovative treatments for endocrine disorders such as diabetes and osteoporosis.

RSS Headlines
Fool UK